ANI Pharmaceuticals Inc

NAS:ANIP (USA)   Ordinary Shares
$ 61.71 -0.02 (-0.03%) 07:08 PM EST
39.06
P/B:
2.86
Volume:
89.23K
Avg Vol (2M):
142.31K
Also Trade In:
Volume:
89.23K
Avg Vol (2M):
142.31K

Business Description

ANI Pharmaceuticals Inc
NAICS : 325414 SIC : 2836
ISIN : US00182C1036

Share Class Description:

ANIP: Ordinary Shares
Description
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.84
Equity-to-Asset 0.52
Debt-to-Equity 0.6
Debt-to-EBITDA 2.25
Interest Coverage 2.21
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.02
Distress
Grey
Safe
Beneish M-Score -2.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 20.22
9-Day RSI 27.16
14-Day RSI 32.7
6-1 Month Momentum % 26.38
12-1 Month Momentum % 42.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.95
Quick Ratio 3.12
Cash Ratio 1.74
Days Inventory 204.14
Days Sales Outstanding 121.46
Days Payable 68.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.3
Shareholder Yield % 0.85

Financials (Next Earnings Date:2024-08-09 Est.)

ANIP's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ANIP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ANI Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 517.46
EPS (TTM) ($) 1.58
Beta 0.69
Volatility % 46.69
14-Day RSI 32.7
14-Day ATR ($) 1.844415
20-Day SMA ($) 65.6505
12-1 Month Momentum % 42.44
52-Week Range ($) 44.27 - 70.81
Shares Outstanding (Mil) 20.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ANI Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

ANI Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ANI Pharmaceuticals Inc Frequently Asked Questions

What is ANI Pharmaceuticals Inc(ANIP)'s stock price today?
The current price of ANIP is $61.71. The 52 week high of ANIP is $70.81 and 52 week low is $44.27.
When is next earnings date of ANI Pharmaceuticals Inc(ANIP)?
The next earnings date of ANI Pharmaceuticals Inc(ANIP) is 2024-08-09 Est..
Does ANI Pharmaceuticals Inc(ANIP) pay dividends? If so, how much?
ANI Pharmaceuticals Inc(ANIP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1